PubMed · 8386645
Ejaculatory dysfunction after retroperitoneal lymphadenectomy.
Abstract
The effects of retroperitoneal lymphadenectomy on ejaculation have been examined in 186 patients who had removal of residual masses after chemotherapy for metastatic non-seminomatous germ cell tumours. The results were analysed for significance using a chi 2 test of independence. Forty-one men (22%) permanently lost ejaculation postoperatively. The larger the size of the mass removed, the more likely the patient was to have ejaculatory failure (< 4 cm = 4%, 4-8 cm = 17%, > 8 cm = 58%; p < 0.005). Removal of bilateral masses was more likely to result in loss of ejaculation than unilateral masses (45 and 12%, respectively, p < 0.005). There has been significantly less postoperative ejaculatory dysfunction since 1984 when a nerve sparing dissection was introduced (before 1984 36%, since 1984 16%, p < 0.005). The incidence of ejaculatory dysfunction following retroperitoneal lymphadenectomy is therefore determined by the size and position of residual lymph node masses after chemotherapy and can be kept to a minimum by a careful nerve sparing operative technique.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
D R Jones, A R Norman, A Horwich, W F Hendry. 1993. Ejaculatory dysfunction after retroperitoneal lymphadenectomy.. https://doi.org/10.1159/000474588
Cite the original work for its findings. Save a collection to share your selection of sources.